Early-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants

Status Recruiting

Clinical Trial Summary

Bronchopulmonary dysplasia (BPD) is a common, major complication of premature birth, associated with developmental and health consequences that continue into adulthood. Prediction of who will have these problems is challenging using traditional definitions of disease. It is believed that underdevelopment and injury occur in both lung tissue and the blood vessels in the lungs, with a sophisticated interplay between them that contributes to lung disease seen in prematurity. New magnetic resonance imaging (MRI) techniques can delineate tissue structure with unprecedented granularity, assessing lung tissue, blood vessels, and their interplay. The ability to identify, at an early stage, those infants destined for chronic lung disease with greater certainty will be useful in counseling families and critical for the effective introduction of promising new BPD therapies. 319 infants born less than 29 weeks gestation will be recruited from 4 centres, including 5 babies who received stem cell therapy in a clinical trial. Babies will be evaluated at 36 weeks post-conception with lung MRI, oscillometry (lung function), echocardiogram (heart ultrasound), and oscillometry. Lung health will be assessed every 3 months by phone questionnaire and chart review. At 18-21 months post-conception, babies will undergo neurodevelopmental assessment and lung function testing. The investigators will look at how well baseline MRI markers predict subsequent lung health and development, independently and combined with echocardiogram, lung ultrasound, and traditional markers of BPD. The investigators anticipate that these new MRI markers will measure lung health safely and longitudinally in babies born extremely preterm. By identifying predictors of longer-term lung disease, clinicians will be able to allocate resources to babies at the highest risk of severe disease. Further, The investigators envision that MRI will help identify babies who would benefit most from interventions like stem cell therapy and be useful for evaluation of future treatments.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06065215
Study type	Observational
Source	Children's Hospital of Eastern Ontario
Contact	Sherri Katz
Phone	(613) 737-7600
Email	skatz@cheo.on.ca
Status	Recruiting
Phase
Start date	March 30, 2024
Completion date	June 30, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04508270` - Significance of Early Mobilization After VATS-L
Recruiting	`NCT06063798` - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery	N/A
Recruiting	`NCT03197701` - Maximal Effort-dependent Respiratory Flow Rates	N/A
Active, not recruiting	`NCT03659864` - The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles	N/A
Completed	`NCT01048021` - Pulmonary Function Changes and Diaphragmatic Paralysis Following Ultrasound Guided Supraclavicular Brachial Plexus Blockade: The Effects of Decreased Local Anesthetic Volume	N/A
Recruiting	`NCT05668624` - Sustainable Household Energy Adoption in Rwanda (SHEAR)	N/A
Completed	`NCT03500614` - The Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates	N/A
Recruiting	`NCT04611243` - Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
Recruiting	`NCT01609712` - Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation	N/A
Completed	`NCT01593657` - Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery	N/A
Not yet recruiting	`NCT04747535` - Continuous Positive Airway Pressure After Abdominal Surgery	N/A
Completed	`NCT04767477` - Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors	N/A
Completed	`NCT01004146` - Pre-op Use of Incentive Spirometry in Obese Patients	N/A
Completed	`NCT06389734` - Combining Manual Soft Tissue Release and Exercise Training in COPD: the Effect on LF, EC, and CAF	N/A
Completed	`NCT04316234` - Acute Health Effects of Passive Vape Among COPD Patients	N/A
Completed	`NCT03237221` - Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma
Completed	`NCT02245178` - Lung Function Decline and Disease Risk From Young Adulthood to Middle Age
Completed	`NCT00706277` - Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function	Phase 4
Recruiting	`NCT04322422` - Clinical Characteristics and Treatment of Chest Tightness Variant Asthma	N/A
Completed	`NCT01169038` - Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Early-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants Born Extremely Preterm (EMBLEM) — EMBLEM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms